Serum sodium, potassium, and magnesium in children with epilepsy treated with levetiracetam monotherapy: A prospective study.
作者信息
Attilakos Achilleas, Garoufi Anastasia, Paschalidou Maria, Tsirouda Maria, Siafakas Nikos, Dinopoulos Argiris
机构信息
Third Department of Pediatrics, National and Kapodistrian University of Athens, "Attikon" Hospital, Athens, Greece.
Second Department of Pediatrics, National and Kapodistrian University of Athens, "Panagiotis and Aglaia Kyriakou" Children's Hospital Athens, Athens, Greece.
出版信息
CNS Neurosci Ther. 2018 Sep;24(9):846-847. doi: 10.1111/cns.12868. Epub 2018 Apr 23.
Abstract
摘要
相似文献
1
Serum sodium, potassium, and magnesium in children with epilepsy treated with levetiracetam monotherapy: A prospective study.
CNS Neurosci Ther. 2018 Sep;24(9):846-847. doi: 10.1111/cns.12868. Epub 2018 Apr 23.
2
Monitoring of biochemical parameters and coagulation tests in children with epilepsy treated with levetiracetam monotherapy.
Childs Nerv Syst. 2019 Nov;35(11):2033-2034. doi: 10.1007/s00381-019-04225-w. Epub 2019 May 31.
3
Effect of levetiracetam monotherapy on lipid profiles and thyroid hormones in children with epilepsy: A prospective study.
Epilepsy Res. 2019 Sep;155:106162. doi: 10.1016/j.eplepsyres.2019.106162. Epub 2019 Jul 4.
4
Effectiveness of Levetiracetam Monotherapy in Pediatric Patients With Epilepsy.
J Child Neurol. 2019 Sep;34(10):593-597. doi: 10.1177/0883073819846804. Epub 2019 May 22.
5
Long-term effect of levetiracetam monotherapy on haematological parameters in children with epilepsy: A prospective study.
Epilepsy Res. 2018 Sep;145:160-162. doi: 10.1016/j.eplepsyres.2018.07.001. Epub 2018 Jul 6.
6
The Efficacy and Tolerability of Levetiracetam as a First Line Monotherapy in Childhood Epilepsy.
Ir Med J. 2020 Feb 13;113(2):18.
7
Levetiracetam Monotherapy in Children with Epilepsy: A Systematic Review.
CNS Drugs. 2015 May;29(5):371-82. doi: 10.1007/s40263-015-0248-9.
8
Intravenous levetiracetam in children with seizures: a prospective safety study.
J Child Neurol. 2010 May;25(5):551-5. doi: 10.1177/0883073809348795.
9
The efficacy, tolerability and safety of levetiracetam therapy in a pediatric population.
Seizure. 2016 Mar;36:16-21. doi: 10.1016/j.seizure.2016.01.017. Epub 2016 Feb 12.
10
Levetiracetam monotherapy for the treatment of infants with epilepsy.
Seizure. 2018 Mar;56:73-77. doi: 10.1016/j.seizure.2018.02.006. Epub 2018 Feb 12.
本文引用的文献
1
Levetiracetam-induced hyponatremia.
Acta Neurol Belg. 2018 Mar;118(1):123-124. doi: 10.1007/s13760-017-0825-4. Epub 2017 Jul 28.
2
The first case of levetiracetam-induced and tolvaptan-resistant hyponatremia.
Turk Kardiyol Dern Ars. 2015 Apr;43(3):284-7. doi: 10.5543/tkda.2015.45735.
3
Levetiracetam-associated Hypokalemia and Hypomagnesaemia among Two Patients Treated for Seizures.
CNS Neurosci Ther. 2015 Jun;21(6):539. doi: 10.1111/cns.12398. Epub 2015 Apr 21.
4
Hypokalemia and hypomagnesaemia related to levetiracetam use.
J Clin Neurosci. 2014 Nov;21(11):1989-90. doi: 10.1016/j.jocn.2014.03.013. Epub 2014 Jun 3.
5
Levetiracetam: a review of its use in epilepsy.
Drugs. 2011 Mar 5;71(4):489-514. doi: 10.2165/11204490-000000000-00000.
6
[Levetiracetam-associated hyponatremia].
Med Clin (Barc). 2010 Sep 18;135(9):429-30. doi: 10.1016/j.medcli.2009.07.007. Epub 2009 Sep 24.
7
Levetiracetam-associated hyponatremia.
Seizure. 2008 Jun;17(4):389-90. doi: 10.1016/j.seizure.2007.10.007.
8
Hyponatremia associated with repeated use of levetiracetam.
Epilepsia. 2005 Jun;46(6):972-3. doi: 10.1111/j.1528-1167.2005.64004.x.
Zotero 插件